Skip to Content

Duramune Max 5-CvK The Puppyshot

This page contains information on Duramune Max 5-CvK The Puppyshot for veterinary use.
The information provided typically includes the following:
  • Duramune Max 5-CvK The Puppyshot Indications
  • Warnings and cautions for Duramune Max 5-CvK The Puppyshot
  • Direction and dosage information for Duramune Max 5-CvK The Puppyshot

Duramune Max 5-CvK The Puppyshot

This treatment applies to the following species:
Company: Elanco US

Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine

Modified Live and Killed Virus

For use in animals only

This product has been shown effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine coronavirus, canine parainfluenza and canine parvovirus (CPV). The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product contains a CPV 2b strain which has been demonstrated effective against disease caused by CPV 2c in puppies with CPV maternal antibody.

Directions For Use

General directions: Aseptically rehydrate Duramune Max 5 with Canine Coronavirus vaccine supplied. Administer one 1 mL dose subcutaneously.

Primary vaccination: The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
All dogs should initially receive one dose of Duramune Max 5-CvK and a second dose 2 to 3 weeks later.

Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended

Duramune Max 5-CvK The Puppyshot Caution

Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Inactivate all unused contents before disposal. In case of human exposure, contact a physician.

Gentamicin and thimerosal added as preservatives.

Duramune Max 5-CvK The Puppyshot Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Duramune, The Puppyshot, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, IA 50501

Phone: 888-545-5973

VLN/PCN 196/1599.29

25 Doses

25 Vials of Vaccine plus 25 x 1 mL Vials of Diluent

YL102084X

CPN: 1943010.2

ELANCO US INC.
FORT DODGE, IA, 50501
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the Duramune Max 5-CvK The Puppyshot information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2019-09-30

Hide